Rare diseases
Investigational molecules
Locations
Block A Planta 1 Pureta 3 Edificio Naorte 4, Carretera De Valldemossa Km 7 Parcbit, 07121 Palma, Spain
Laminar Pharmaceuticals S.A. focuses on clinical research in newly diagnosed primary glioblastoma multiforme, with interest centered on disease control and survival outcomes in aggressive brain tumours.
The sponsor’s clinical development activity in this area is directed toward treatment approaches for patients with newly diagnosed disease.
Laminar Pharmaceuticals S.A. runs clinical trials in conditions such as Glioblastoma, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
